Table 3. Secondary Outcomes at Baseline and 12 Months Among the CHW and EUC Groupsa.
| Secondary Outcome | Participant Group | |||
|---|---|---|---|---|
| EUC (n = 104) |
CHW (n = 111) |
|||
| Baseline | 12 Months | Baseline | 12 Months | |
| BMI, mean (SD) | 32.8 (8.0) | 32.7 (7.7) | 32.4 (7.1) | 32.1 (6.7) |
| Fruit and vegetable intake, mean (SD), servings/db | 2.6 (1.6) | 3.3 (2.1) | 2.5 (1.6) | 2.7 (1.6) |
| Sedentary, No. (%)c | 56 (53.9) | 58 (55.8) | 56 (50.5) | 57 (51.4) |
| Medication adherence score, mean (SD)d | 5.5 (1.9) | 5.4 (1.9) | 5.8 (1.6) | 5.4 (1.7) |
| Medication regimen intensification, No. (%)e | ||||
| Blood pressure | NA | 24 (23.3) | NA | 24 (21.8) |
| Type 2 diabetesf | NA | 33 (31.7) | NA | 48 (43.6) |
| Lowering of lipid levelsg | NA | 16 (15.5) | NA | 29 (26.4) |
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CHW, community health worker; EUC, enhanced usual care; NA, not applicable.
a
We did not find any significant differences between baseline and 12-month changes and no difference-in-differences across groups.
b
Measured using the Centers for Disease Control and Prevention Fruit and Vegetable Consumption Questionnaire.
c
Measured by the International Physical Activity Questionnaire.
d
One patient was missing in each group. Measure described by Morisky et al. Scores range from 1 to 8, with higher scores indicating greater adherence.
e
Measure described by Carrasquillo et al. For EUC, n = 103; for CHW, n = 110.
f
P = .053.
g
P = .08.